Outsourcing Outlook

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-04-02-2002, Volume 26, Issue 4

The author discusses the current soft demand and excess capacity in the contract-manufacturing market of small molecule actives and intermediates.

Related Content:

Bio/Pharma BusinessOutsourcingContract Manufacturing, GeneralPharmaceutical Technology-04-02-2002
CN Bio Forms Strategic Partnership with Pharmaron to Develop OOC Technologies
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
Paige, Sonrai Form Partnership to Harness AI for Precision Medicine R&D